Trial intelligence / Profile preview

Psilocybin-Assisted Therapy for Demoralization in Hospice Care

NCT04950608Phase 2Completed

Start
Mar 2022
Primary completion
Jul 2024
Modality
Orthosteric Ligands
Countries
1
01

Overview

A Phase 2 trial of psilocybin. Started Mar 2022; status: completed.

02

Drugs

psilocybin

Beyond the preview

Go deeper on NCT04950608.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT04950608.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call